Clinical Research Directory
Browse clinical research sites, groups, and studies.
Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)
Sponsor: Checkmab S.r.l.
Summary
The first objective of the project consists in the preclinical validation of new possible molecular targets associated with intratumoral T regulatory cells. The second objective consists in the selection of monoclonal antibodies with therapeutic potential, specific for the selected targets.
Official title: Nuovi Bersagli Per lo Sviluppo di Anticorpi Monoclonali Per Immunoterapia - (Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
600
Start Date
2023-04-01
Completion Date
2026-06-30
Last Updated
2025-02-24
Healthy Volunteers
Yes
Conditions
Locations (1)
S.C. Medicina Trasfusionale - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy